Disclosures for "A Standardized 40 Hz Vibrotactile Stimulation Platform for Alzheimer’s Disease"
-
Dr. Xi has received personal compensation for serving as an employee of AriBio Co., Ltd.. Dr. Xi has received personal compensation for serving as an employee of McKinsey & Company. Dr. Xi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for McKinsey & Company.
-
Mr. Shin has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Mr. Ha has received personal compensation for serving as an employee of AriBio Co. Ltd. Mr. Ha has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for AriBio Co. Ltd.. Mr. Ha has stock in AriBio Co. Ltd.. Mr. Ha has stock in Solux Ltd.. An immediate family member of Mr. Ha has stock in AriBio Co. Ltd.. The institution of Mr. Ha has received research support from Ministry of Health and Welfair, Republic of Korea.
-
Dr. Choung has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Ko has nothing to disclose.
-
Mr. Kim has received personal compensation for serving as an employee of AriBio Co., Ltd.. An immediate family member of Mr. Kim has stock in AriBio Co., Ltd.. The institution of an immediate family member of Mr. Kim has received research support from National Research Council of Science & Technology (NST) through the Aging Convergence Research Center. Mr. Kim has received intellectual property interests from a discovery or technology relating to health care.
-
Miss Fomenko has received personal compensation for serving as an employee of AriBio Co., Ltd.. Miss Fomenko has received personal compensation for serving as an employee of Cognito Therapeutics Inc..
-
Dr. Ko has nothing to disclose.